Compression Therapy Market

The report "Compression Therapy Market by Technique (Static, Dynamic), Product (Bandage, Wraps, Stockings, Tapes, Braces, Pneumatic), Application (Varicose Vein, DVT, Lymphedema, Ulcers), Distribution Channel (Clinics, Pharmacy, E-Commerce) - Global Forecasts to 2030", is projected to reach USD 5.9 billion by 2030 from an estimated USD 4.5 billion in 2025, at a CAGR of 5.5% during the forecast period. The market for compression therapy is primarily driven by the increasing prevalence of chronic illnesses such as varicose veins, deep vein thrombosis (DVT), and lymphedema, all of which require effective treatments. There is a growing understanding of the therapeutic benefits of compression therapy, which helps prevent postoperative complications and improves circulation, further fostering market growth.

Browse 232 market data Tables and 61 Figures spread through 278 Pages and in-depth TOC on "Compression Therapy Market by Technique (Static, Dynamic), Product (Bandage, Wraps, Stockings, Tapes, Braces, Pneumatic), Application (Varicose Vein, DVT, Lymphedema, Ulcers), Distribution Channel (Clinics, Pharmacy, E-Commerce) - Global Forecasts to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/compression-therapy-market-146548022.html

Enhancements in product design, including the use of smart technologies for monitoring and real-time data tracking, significantly improve patient outcomes and allow for personalized treatment options. Additionally, the rising demand for non-invasive treatment alternatives and favorable healthcare regulations in advanced nations contribute to market expansion as more patients opt for these therapies over surgical interventions.

However, one major challenge facing the compression therapy market is the high cost associated with advanced compression devices, which can limit accessibility for patients in low-income areas. Despite the proven effectiveness of compression therapy, inconsistent insurance coverage creates financial barriers that hinder widespread adoption.

The varicose veins segment dominated the market in 2024.

The varicose veins segment is the leading segment of the compression therapy market due to its direct link to the rising prevalence of this condition, especially among aging populations and individuals whose jobs require prolonged standing. Compression therapy effectively alleviates symptoms of varicose veins, such as pain and swelling, by enhancing venous return and reducing pressure in the affected vessels. The growing preference for non-invasive treatments, along with an increasing demand for home-based care options, positions compression therapy as an important therapeutic choice. Additionally, advancements in the design of compression garments, which offer improved comfort and effectiveness, further strengthen its role in this field.

The compression bandages segment held the largest market share in 2024.

Compression bandages dominate the compression therapy market, particularly due to their essential role in managing venous leg ulcers (VLUs) and early-stage lymphedema during decongestive therapy. Multi-layer systems allow clinicians to tailor pressure levels based on limb circumference changes, making them more suitable than fixed-pressure garments in active wound management. Clinical protocols, such as those recommended by NICE in the UK, prioritize bandage systems for ulcer healing. Companies like Essity (with its JOBST Comprilan and Leukotape product lines) and 3M (offering the Coban 2 Layer Compression System) are key players driving adoption through specialized solutions designed for effective pressure distribution, moisture control, and ease of application.

The compression therapy market is experiencing significant innovation, especially with the integration of digital health technologies. These advancements include pressure-sensing systems that provide real-time feedback to both clinicians and patients. Velcro-based adjustable wraps are becoming more popular, enabling users to manage their therapy easily outside of clinical settings, which supports the trend toward decentralized care. Custom-fit solutions, created using 3D scanning or sizing tools, are also gaining traction as they offer better therapeutic outcomes through precise compression.

To address challenges related to long-term wear, companies are developing lightweight, breathable fabrics that minimize skin irritation. Additionally, sustainability is becoming a key differentiator, with some companies exploring biodegradable or reusable compression materials to help reduce medical waste.

The US is expected to hold the largest share of the North American market during the forecast period.

The US holds a significant share of the compression therapy market for several important reasons. First, there is a high prevalence of chronic venous diseases, such as varicose veins and lymphedema, which creates a consistent demand for compression therapies. Additionally, the aging population contributes significantly to this demand, as older adults are more susceptible to conditions that require these treatments.

Moreover, the growing number of orthopedic surgeries and the subsequent need for post-surgical care also drive the market, as compression therapy is commonly used to manage swelling and promote recovery. The US also benefits from a robust healthcare infrastructure, widespread access to specialized care, and favorable reimbursement policies, all of which encourage the adoption of compression therapy.

Finally, the presence of major companies, such as 3M and Essity, which are leaders in product innovation and availability, ensures the market's ongoing growth and accessibility.

As of 2024, the key players in the compression therapy market are BSN Medical (Germany), medi GmbH & Co. KG (Germany), 3M Company (US), Sanyleg S.r.l. (Italy), SIGVARIS AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), VENOSAN (Switzerland), DJO Global, Inc. (US), Essity AB (Sweden), Smith & Nephew Plc (UK), Medline Industries, LP (US), Gottfried Medical, Inc. (US), Stryker Corporation (US), Össur hf. (Iceland), Mego Afek AC Ltd. (Israel), ConvaTec Group Plc (UK), Cardinal Health, Inc. (US), Spectrum Healthcare (US), THUASNE (France), and Medtronic Plc (Ireland).

Don’t miss out on business opportunities in Compression Therapy Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/